Back

Results - Announcements

Sales rise 29.22% to Rs 5.13 crore

Beryl Drugs standalone net profit rises 273.33% in the March 2026 quarter

29-May-2026, 07:42
Net profit of Beryl Drugs rose 273.33% to Rs 0.56 crore in the quarter ended March 2026 as against Rs 0.15 crore during the previous quarter ended March 2025. Sales rose 29.22% to Rs 5.13 crore in the quarter ended March 2026 as against Rs 3.97 crore during the previous quarter ended March 2025.

For the full year,net profit declined 27.59% to Rs 0.42 crore in the year ended March 2026 as against Rs 0.58 crore during the previous year ended March 2025. Sales declined 11.02% to Rs 18.82 crore in the year ended March 2026 as against Rs 21.15 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	5.13	3.97	29	18.82	21.15	-11
OPM %	25.93	12.59	-	12.81	12.53	-
PBDT	1.26	0.42	200	2.07	2.12	-2
PBT	0.86	0.10	760	0.58	0.87	-33
NP	0.56	0.15	273	0.42	0.58	-28